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Objective: This study aimed to determine the safety and clinical effect of artificial shrinkage (AS) in terms of assisted hatching of fresh blasto-
cysts. Also, we evaluated the correlation between patient age and the effect of AS on clinical outcome. 
Methods: Two AS methods, using a 29-gauge needle and laser pulse, were compared. Seventy-three blastocysts were shrunk using a 29-gauge 
needle and the same number of other blastocysts were shrunk by a laser pulse. We evaluated the shrunken blastocysts hourly and considered 
them viable if they re-expanded >70%. Blastocyst transfer cycles (n=134) were divided into two groups: a control group consisted of the cy-
cles whose intact embryos were transferred (n=100), while the AS group consisted of the cycles whose embryos were replaced following AS 
(n=34). The implantation and pregnancy rates of the control group and AS group were compared (p<0.05). 
Results: The re-expansion rates of the 29-gauge needle and laser pulse AS groups were similar (56 [76.7%] vs. 62 [84.9%], respectively). All of 
the remaining shrunken blastocysts were re-expanded within 2 hours. There was no degeneration of shrunken blastocysts. The total and clini-
cal pregnancy rate of the AS group (23 [67.6%]; 20 [58.8%], respectively) was significantly higher than that of the control group (47 [47.0%]; 39 
[39.0%], respectively). In the older patient group, there was no difference in the clinical outcomes between the AS and control groups. 
Conclusion: These results suggest that AS of blastocoele cavity, followed by the transfer, would be a useful approach to improve the clinical 
outcome in cycles in which fresh blastocyst stage embryos are transferred. 
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Introduction
In developing from the morula to the blastocyst, embryos undergo 
dramatic morphologic changes. When blastocysts expand, fluid gra-
dually accumulates in the blastocoel-mediated sodium pump (Na
+, 
K
+, ATPase) [1], resulting in increased pressure on both the trophec-
toderm and zona pellucida (ZP). At the same time, trophectoderm 
cells secrete lysins that are involved in ZP thinning and hatching. Ex-
pansion and ZP thinning occur in mammalian blastocysts prior to 
hatching [2-4]. Contraction-expansion cycles, as well as expansion 
and ZP thinning of blastocysts, have been documented by time-lapse 
video recording [5,6]. 
The rationale of artificial shrinkage (AS) is based on contraction-ex-
pansion cycles and cytoplasmic extension of the trophectoderm of 
the blastocyst. The mechanism of blastocoel collapse and recovery of 
trophectoderm rupture is unclear. Whatever causes a collapse of the 
blastocyst, shrunken blastocysts have the potential to gradually re-
cover their spheroidal shape. The AS technique is widely used and 
considered an essential step to improve the efficiency of vitrification. 
Researchers using AS before vitrification of blastocysts have reported 
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higher implantation and clinical pregnancy rates [7-12].
The advantage of AS is that ice crystal formation can be avoided by 
reducing the fluid content of the blastocoel [7]. Some researchers as-
sume that creating a large hole in the ZP with any of various AS tools 
(i.e., glass micro-needle, injection needle, micropipetting with a hand-
drawn Pasteur pipette, 29-gauge needle, or laser pulse) has some 
kind of effect on assisted hatching (AH) [13,14]. In the process of AS, 
various AS tools create physical damage to the ZP as well as to the 
trophectoderm. It is assumed that re-expanding the blastocyst dur-
ing warming eases hatching through the ZP-damaged areas. In fact, 
most thawed blastocysts with AS have a higher hatching rate, wheth-
er or not they hatch through the ZP-damaged areas. 
Although blastocyst transfer has provided good clinical results, re-
searchers have become increasingly aware that it is more difficult to 
obtain a certain pregnancy rate [15,16]. Thus, some researchers have 
attempted to include an additional process before blastocyst transfer 
to achieve a higher pregnancy rate. Fong et al. [17] attempted to re-
move the total ZP with pronase before blastocyst transfer, Turker [18] 
attempted to make a large hole in the ZP with acid Tyrode’s solution, 
and Goto et al. [19] attempted to stimulate the endometrium by in-
jection of embryo culture supernatant into the uterus. We attempted 
to use the AS technique on fresh blastocysts before transfer.
The objective of this study was to determine the impact of AS on 
fresh blastocysts, and to determine whether or not AS had an effect, 
such as assisted hatching, by comparing clinical outcomes. We evalu-
ated the correlation between patient age and the effect of AS on clin-
ical outcome. 
Methods
1. Patients and IVF
Patients who entered our blastocyst transfer program and agreed 
to perform assisted hatching were≥36 years of age or had previous 
repeat failures of cleavage-stage embryo transfers. Between July and 
December 2008, 100 cycles were randomly selected as a control group. 
We applied the 29-gauge needle AS technique to 34 cycles. In each 
group (control and AS groups), we evaluated the effect of the AS te-
chnique on patients ≥36 years of age. Patients were treated with 
GnRH agonist and hMG in according to a long- or a short-treatment 
protocol. When two and more follicles reached 18 mm in diameter, 
5,000 IU of hCG (Ovidrel; Merk-Serono, Bari, Italy) was administered. 
Oocytes were retrieved transvaginally 36-38 hours after hCG injection 
and the oocytes were inseminated by conventional IVF or ICSI. 
2. Embryo culture
Fertilization was assessed 15-18 hours after insemination by the 
presence of two pronuclei. Zygotes were washed and cultured in 
groups <5 in Sydney IVF Cleavage Medium (CM; COOK, Brisbane, 
Australia) for 48 hours, then in Sydney IVF Blastocyst Medium (BM; 
COOK) for another 48-71 hours. All culturing of embryos was per-
formed in a CO2:O2:N2 (6%:5%:89%) environment. On day 5, blasto-
cysts were scored depending on the developmental stage and grad-
ed according to quality criteria [20].
3. Artificial shrinkage of expanded blastocysts
Son et al. [8] previously described the mechanical technique of shrin-
kage using two 29-gauge needles. Briefly, after holding the expand-
ed blastocyst with the flat side of a needle and placing the inner cell 
mass (ICM) at the 12 or 6 o’clock position, a needle was pushed throu-
gh the trophectoderm cell in the blastocoel cavity until the cavity 
shrank. Contraction of the blastocysts was observed after 30 seconds 
to 1 minute. After complete shrinkage of the blastocoel, the blasto-
cysts were cultured in BM before embryo transfer. 
A laser system (ZILOS-tk Laser Zona Drill System; Hamilton Thorn 
Bioscience, Inc., Beverly, MA, USA) was introduced to compare with 
the 29-gauge needle AS. The process of the AS was followed by Mu-
kaida’s method [14]. The ICM should be placed away from the target-
ed point of the laser pulse. A single laser pulse (300 μs) was delivered 
to the outer periphery of the trophectoderm at the junction between 
the cells. It was sufficient to induce complete shrinkage within 1-2 
minutes. After complete shrinkage of the blastocoel, the blastocysts 
were cultured in the same media. 
4. Evaluation of impact of AS on fresh blastocysts
Several previous studies have concluded that AS before vitrification 
is a useful approach for improving clinical outcomes and guarantee-
ing the safety of the AS technique for human blastocysts. With a sligh-
tly different perspective, we attempted to determine the impact of 
AS on fresh blastocysts that were surplus embryos for cryopreserva-
tion. A 29-gauge needle and laser pulse AS were compared. Seventy-
three blastocysts were shrunk by using a 29-gauge needle and the 
same number of other blastocysts were shrunk using a laser pulse. 
After AS was performed, every blastocyst was evaluated hourly until 
the re-expansion rate was up to 70%. We confirmed that 70% of the 
re-expanded blastocysts were viable. After observing for 2 hours, the 
highest quality blastocysts were cryopreserved and the others were 
discarded. 
Assisted hatching of blastocysts and AS before vitrification of every 
blastocyst has already been permitted by the policy of the Maria Fer-
tility Hospital Institutional Review Board. The evaluation of re-expan-
ded blastocysts was treated as a part of the whole freezing process.
5. Blastocyst transfer and assessment of pregnancy
On the morning of embryo transfer (ET), we selected 2 or 3 good www.eCERM.org
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quality blastocysts and performed AS before transfer. After 2 or 2.5 
hours, we selected the best quality re-expanded blastocysts and trans-
ferred them. We were limited to transfering two blastocysts. Only a 
few patients received three blastocysts, based on their clinical history 
(i.e., repeat failures or age ≥36 years). Pregnancy was assessed by 
serum hCG 14 days after administration of progesterone, then im-
plantation was confirmed by the presence of a gestational sac. Clini-
cal pregnancy was confirmed by the presence of fetal heart activity. 
6. Statistics
The data were examined by χ
2 analysis to determine whether dif-
ferences in implantation and pregnancy rates were significant be-
tween the control and AS groups. 
Results
We evaluated the impact of AS on fresh blastocysts by observing 
the rate of re-expansion to 70% of the original volume. The 29-gauge 
needle and laser pulse AS were compared (Table 1). Seventy-three 
blastocysts were shrunk by using a 29-gauge needle; 56 blastocysts 
(76.7%) were re-expanded up to at least 70% within 1 hour (Figure 1). 
The remaining blastocysts (17 [23.3%]) were re-expanded within 2 
hours. 
The same number of other blastocysts were shrunk using a laser 
pulse; 62 blastocysts (84.9%) were re-expanded up to at least 70% 
within 1 hour. The remaining blastocysts (11 [15.1%]) were re-ex-
panded within 2 hours. All blastocysts were re-expanded up to 70% 
within 2 hours. There was no degeneration of the shrunken blasto-
cysts.  
The re-expansion rates using the 29-gauge needle and laser pulse 
AS were similar. Nearly 80% of the shrunken blastocysts were re-ex-
panded within 1 hour. All of the remaining shrunken blastocysts were 
re-expanded within 2 hours. 
Based on previous results, we applied the AS technique clinically. 
Table 2 summarizes the clinical outcome comparing the control and 
AS groups. Laser pulse AS had not been applied by that time. The 
mean number of blastocyst transfers was quite similar between the 
control and AS groups. The implantation rate of the 29-gauge needle 




Time for re-expansion (hr) Survival 
rate 1  2 
29-gauge needle AS 73 56 (76.7) 17 (23.3) 73 (100)
Laser pulse AS 73 62 (84.9) 11 (15.1) 73 (100)
Total 146  118 (80.8) 28 (19.2) 146 (100)
Values are presented as number (%).
AS, artificial shrinkage.
Figure 1. Blastocyst shrinkage and re-expansion (≥70%) using a 29-gauge needle (A) and laser pulse (B) (magnification×200).
A
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AS group was higher than the control group, but the difference was 
not statistically significant. The total and clinical pregnancy rates of 
the AS group were significantly higher than those of the control group. 
In patients with an age of ≥36 years, the clinical outcome of the AS 
group was higher than that of the control group, but the difference 
was not statistically significant. 
Discussion
This study demonstrated that AS of fresh blastocysts before transfer 
had very encouraging clinical results. We confirmed the safety of la-
ser pulse AS as well as 29-gauge needle AS on fresh blastocysts. Our 
laboratory has previously reported a vitrification method for human 
blastocysts on electron microscopy grids combined with AS using a 
29-gauge needle [8], but we have also published serial studies which 
led to the previous study [21-24]. Thus, we have considerable experi-
ence with AS using a fine needle. Due to our accumulated experi-
ence, we reasoned that physical damage would be minimized. 
As mentioned earlier, AS before vitrification of blastocysts and AH 
of blastocysts has already been permitted by the policy of the Maria 
Fertility Hospital Institutional Review Board. The evaluation of re-ex-
panded blastocysts was treated as a part of the whole freezing pro-
cess. Most of the blastocysts designated for vitrification were re-shrunk 
in the media for cryopreservation. Some blastocysts that did not shr-
ink in the freezing media were cryopreserved without going through 
AS. We had experienced that sometimes a blastocyst was not shrink 
completely. We could not find the reason why some blastocysts shr-
ink incompletely. 
During embryo biopsy for pre-implantation genetic diagnosis (PGD), 
a large hole is created in the ZP of the blastocyst. However, the safety 
of biopsy for PGD is still a matter of debate [25-27]. It appears that 
the effect of AS is less extensive than PGD by comparing several clini-
cal outcomes. We recommend that additional study is needed at the 
DNA/cellular level to determine the effects of AS on fresh blastocysts. 
The advantage of AS is improving blastocyst viability after vitrifica-
tion, which prevents ice crystal damage by reducing fluid within the 
blastocoel cavity [7]. Other researchers have estimated that there 
may be an effect of assisted hatching caused by the formation of a 
large hole in the ZP, especially with 29-gauge needle AS [8]. We have 
confidence that there is a helpful effect of AS in terms of AH. Most 
previous reports on the effect of AH have performed AH on the clea-
vage stage using acid Tyrode’s solution, a mechanical method, or a 
laser [28,29]. Enzymatic treatment of the ZP to completely remove 
the ZP before blastocyst transfer has resulted in a high implantation 
rate [30]. AH at the blastocyst stage needs a more careful approach. 
Some researchers claim that there is no need to do AH on blastocysts 
because they have an intrinsically higher viability than cleavage-stage 
embryos [31]. Our study showed that the AS technique is not harm-
ful to the survival rate of blastocysts, and is worthwhile as a new AH 
technique to perform on blastocysts before transfer. 
Single embryo transfer (SET) is the effective method for reducing 
the IVF multiple pregnancy rate [32]. For SET to be successful, it is 
crucial to have confidence in embryo viability [33]. Blastocyst transfer 
is a better method for diminishing the controversy over embryo via-
bility. Combining a single blastocyst and the AS technique before 
transfer would be a better approach to SET.  
In this study, the tendency for AS to improve the rate of blascto-
cysts having successful implantation and pregnancy in patients aged 
≥36 years was insignificant. Further study is needed to determine 
whether or not AS is helpful in older patients.
In conclusion, this study showed that AS of human blastocysts be-
fore transfer is a clinically useful method. 
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